HS-10502 Combination Treatment in Patients With Advanced Solid Tumors

Clinical trial NCT06769425 · RECRUITING

Trial details

NCT number: NCT06769425
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer HER2-negative Advanced Breast Cancer TNBC Advanced Prostate Cancer Advanced Gastric Cancer

Start date: 2025-05-07
Primary completion: 2026-05-07
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.